January 2001 Issue

FDA Targets Poultry Drugs to Curb Antibiotic Resistance

Action by the Food and Drug Administration (FDA) is forcing off the market two fluoroquinolones used as poultry antibiotics, because of concern their use jeopardizes human health. Consumer groups have pushed for the ban for years, convinced the drugs are contributing to the rising incidence of antibiotic-resistant bacteria in humans (see EN, November 1999). In response to the proposed FDA action, one of the controversial drugs, sarafloxacin, has been voluntarily pulled off the market by its maker. The FDA is now

To continue reading this entire article you must be a paid subscriber.

Subscribe to Environmental Nutrition

Get the next year of Environmental Nutrition for just $20. And access all of our online content - how to fight heart disease, cancer, stroke, diabetes, osteoporosis, Alzheimer's, and dozens of other diseases - free of charge.

Already subscribe but haven't registered for all the benefits of the website? Click here.

Subscriber Log In

Forgot your password? Click Here.